Children’s Hospital Los Angeles Awarded $6 Million from CIRM to Advance CAR T-Cell Therapies in Recurring Solid Tumors in Children
February 29, 2024
CHLA Researchers receive CIRM award to develop regenerative therapy for recurring solid tumors in children.